The laboratories and offices of the COBRE PI, Dr. Igor Roninson, COBRE target faculty Dr. Michael Shtutman, the Co-Directors of the COBRE Microscopy/Flow Cytometry Core, Dr Chang-uk Lim and Dr. Gary Schools, are scattered in various inadequate rooms and laboratories between floors 3 and 7 of the Coker Life Sciences Building (CLS) on the Columbia Campus of USC in space that was temporarily provided to Pharmacy from the Department of Biology. This lack of cohesive modern molecular biology laboratory space is disruptive, inefficient, and raises many obstacles for Dr. Roninson's research program and the CTT COBRE. This A&R request is for $300,000 of support toward a $1,150,000 renovation project on the 7th floor of the Pharmacy wing of CLS that will result in 4,857 s.f. of new modern office and research space for the CTT COBRE and Dr. Roninson's entire program.
Specific Aim 1. To renovate space on the 7th floor of the Pharmacy Wing of the Coker Life Sciences Building on the USC Columbia campus to house the proposed CTT COBRE. This space will provide modern office and laboratory space for (1) the COBRE PI, (2) COBRE target faculty Michael Shtutman, (3) the COBRE Microscopy/Flow Cytometry Core and its Co-directors Dr. Gary Schools and Dr. Chang-uk Lim, and (4) part of the COBRE Functional Genomics Core. Additionally, this space will house the Administrative Coordinator for the COBRE Center for Targeted Therapeutics, a Conference Room, and a Break Room.

Public Health Relevance

This request will complement and complete an extensive renovation of space to accommodate the Center for Translational Therapeutics undertaken by the SC College of Pharmacy, University of South Carolina, to provide first-rate facilities to the CTT group and consolidate a large component of the CTT into contiguous research and office space, to promote interactions and facilitate collaboration

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM109091-05
Application #
9476268
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of South Carolina at Columbia
Department
Type
DUNS #
041387846
City
Columbia
State
SC
Country
United States
Zip Code
29208
Wyatt, Michael D; Reilly, Nicole M; Patel, Shikha et al. (2018) Thiopurine-induced mitotic catastrophe in Rad51d-deficient mammalian cells. Environ Mol Mutagen 59:38-48
Serrao, Anne; Jenkins, Laura M; Chumanevich, Alexander A et al. (2018) Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer. Oncogene 37:4792-4808
Varadaraj, Archana; Magdaleno, Carina; Mythreye, Karthikeyan (2018) Deoxycholate Fractionation of Fibronectin (FN) and Biotinylation Assay to Measure Recycled FN Fibrils in Epithelial Cells. Bio Protoc 8:
Liu, Changlong; Banister, Carolyn E; Weige, Charles C et al. (2018) PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids. Proc Natl Acad Sci U S A 115:E5066-E5075
Yu, Jin; Zhu, Hong; Taheri, Saeid et al. (2018) Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy. J Neuroinflammation 15:277
Jenkins, Laura M; Horst, Ben; Lancaster, Carly L et al. (2018) Dually modified transmembrane proteoglycans in development and disease. Cytokine Growth Factor Rev 39:124-136
Alam, Amer; Küng, Raphael; Kowal, Julia et al. (2018) Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proc Natl Acad Sci U S A 115:E1973-E1982
Liang, Jiaxin; Chen, Mengqian; Hughes, Daniel et al. (2018) CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Cancer Res 78:6594-6606
Chukwurah, Evelyn; Patel, Rekha C (2018) Stress-induced TRBP phosphorylation enhances its interaction with PKR to regulate cellular survival. Sci Rep 8:1020
Singh, Priyanka; Jenkins, Laura M; Horst, Ben et al. (2018) Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis. Cancer Res 78:2978-2989

Showing the most recent 10 out of 49 publications